Doxorubicin Hydrochloride Liposome 25021-0263
Generic: Doxorubicin Hydrochloride
Product NDC
25021-0263- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Suspension, Liposomal
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- March 1, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA219881
Need to source Doxorubicin Hydrochloride Liposome? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Doxorubicin Hydrochloride | 2 mg/mL |
Drug Class
Anthracycline Topoisomerase Inhibitor [EPC]Anthracyclines [CS]Topoisomerase Inhibitors [MoA]
Packaging Options(2)
1 VIAL in 1 CARTON (25021-263-10) / 10 mL in 1 VIAL
1 VIAL in 1 CARTON (25021-263-25) / 25 mL in 1 VIAL